Evidence map›Paper›PMID 27466713›Full record

ArticleNature protocols2016

A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies.

Francesca Magnani, Maria J Serrano-Vega, Yoko Shibata, Saba Abdul-Hussein, Guillaume Lebon, Jennifer Miller-Gallacher, Ankita Singhal, Annette Strege, Jennifer A Thomas, Christopher G Tate

Abstract read
In one paragraph

Article in Nature protocols, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. One-shot design elevates functional expression levels of a voltage-gated potassium channel.Protein science : a publication of the Protein Society · 2024
    Article
  6. Article
  7. eGFP as an All-in-One Tag for Purification of Membrane Proteins.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Structure and activity of a thermally stable mutant of Acanthamoeba actophorin.Acta crystallographica. Section F, Structural biology communications · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. The high-throughput production of membrane proteins.Emerging topics in life sciences · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Francesca MagnaniMRC Laboratory of Molecular Biology, Cambridge, UK.
Maria J Serrano-VegaMRC Laboratory of Molecular Biology, Cambridge, UK.
Yoko ShibataMRC Laboratory of Molecular Biology, Cambridge, UK.
Saba Abdul-HusseinMRC Laboratory of Molecular Biology, Cambridge, UK.
Guillaume LebonMRC Laboratory of Molecular Biology, Cambridge, UK.
Jennifer Miller-GallacherMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0003-0539-0223
Ankita SinghalMRC Laboratory of Molecular Biology, Cambridge, UK.
Annette StregeMRC Laboratory of Molecular Biology, Cambridge, UK.
Jennifer A ThomasMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0003-1065-4131
Christopher G TateMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID 0000-0002-2008-9183

Funding

Biotechnology and Biological Sciences Research Council BB/G003653/1European Research Council 339995Medical Research Council MC_U105197215Wellcome Trust
6 · The paper itself

Abstract

The thermostability of an integral membrane protein (MP) in detergent solution is a key parameter that dictates the likelihood of obtaining well-diffracting crystals that are suitable for structure determination. However, many mammalian MPs are too unstable for crystallization. We developed a thermostabilization strategy based on systematic mutagenesis coupled to a radioligand-binding thermostability assay that can be applied to receptors, ion channels and transporters. It takes ∼6-12 months to thermostabilize a G-protein-coupled receptor (GPCR) containing 300 amino acid (aa) residues. The resulting thermostabilized MPs are more easily crystallized and result in high-quality structures. This methodology has facilitated structure-based drug design applied to GPCRs because it is possible to determine multiple structures of the thermostabilized receptors bound to low-affinity ligands. Protocols and advice are given on how to develop thermostability assays for MPs and how to combine mutations to make an optimally stable mutant suitable for structural studies. The steps in the procedure include the generation of ∼300 site-directed mutants by Ala/Leu scanning mutagenesis, the expression of each mutant in mammalian cells by transient transfection and the identification of thermostable mutants using a thermostability assay that is based on binding of an (125)I-labeled radioligand to the unpurified, detergent-solubilized MP. Individual thermostabilizing point mutations are then combined to make an optimally stable MP that is suitable for structural biology and other biophysical studies.

Indexed as

MutagenesisTemperatureAmino Acid SequenceDetergentsMembrane ProteinsModels, MolecularMutationProtein ConformationProtein StabilitySolubilityDetergentsMembrane Proteins

Identifiers

PMID27466713
PMCPMC5268090

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.